Severe Childhood Respiratory Viral Infections

Advances in Pediatrics

Volumn 56, Issue 1, 2009, Pages 47-73

  Hon, Kam Lun ^a   Leung, Alexander K C ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; HUMAN; PROGNOSIS; RESPIRATORY TRACT INFECTION; REVIEW; VIROLOGY; VIRUS INFECTION;

CHILD; HUMANS; PROGNOSIS; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES;

EID: 72049087711     PISSN: 00653101     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yapd.2009.08.019     Document Type: Review

References (152)

1. Sung R.Y., Chan R.C., Tam J.S., et al. Epidemiology and aetiology of acute bronchiolitis in Hong Kong infants. Epidemiol Infect 108 1 (1992) 147-154
2. Hon K.L., and Nelson E.A. Gender disparity in paediatric hospital admissions. Ann Acad Med Singap 35 12 (2006) 882-888
3. Nelson E.A.S., Tam J.S., Yu L.M., et al. Assessing disease burden of respiratory disorders in Hong Kong children with hospital discharge data and linked laboratory data. Hong Kong Med J 13 2 (2007) 114-121
4. O'Kelly E.A., and Hillary I.B. Epidemiology of respiratory syncytial virus infection among infants over three winter seasons. Ir J Med Sci 160 1 (1991) 12-16
5. Kristensen K., Dahm T., Frederiksen P.S., et al. Epidemiology of respiratory syncytial virus infection requiring hospitalization in East Denmark. Pediatr Infect Dis J 17 11 (1998) 996-1000
6. Chan P.K., Sung R.Y., Fung K.S., et al. Epidemiology of respiratory syncytial virus infection among paediatric patients in Hong Kong: seasonality and disease impact. Epidemiol Infect 123 2 (1999) 257-262
7. Chiu S.S., Tse C.Y., Lau Y.L., et al. Influenza A infection is an important cause of febrile seizures. [see comment]. Pediatrics 108 4 (2001) E63
8. Chiu S.S., Lau Y.L., Chan K.H., et al. Influenza-related hospitalizations among children in Hong Kong. [see comment]. N Engl J Med 347 26 (2002) 2097-2103
9. Nicholson K.G., McNally T., Silverman M., et al. Influenza-related hospitalizations among young children in Leicestershire. Pediatr Infect Dis J 22 10 Suppl (2003) S228-S230
10. van Woensel J.B., van Aalderen W.M., and Kimpen J.L. Viral lower respiratory tract infection in infants and young children. BMJ 327 7405 (2003) 36-40
11. Rojo J.C., Ruiz-Contreras J., Fernandez M.B., et al. Influenza-related hospitalizations in children younger than three years of age. Pediatr Infect Dis J 25 7 (2006) 596-601
12. Sung R.Y., Chan P.K., Tsen T., et al. Identification of viral and atypical bacterial pathogens in children hospitalized with acute respiratory infections in Hong Kong by multiplex PCR assays. J Med Virol 81 1 (2009) 153-159
13. Keren R., Zaoutis T.E., Saddlemire S., et al. Direct medical cost of influenza-related hospitalizations in children. Pediatrics 118 5 (2006) e1321-e1327
14. Straliotto S.M., Siqueira M.M., Machado V., et al. Respiratory viruses in the pediatric intensive care unit: prevalence and clinical aspects. Mem Inst Oswaldo Cruz 99 8 (2004) 883-887
15. Milne B.G., Williams S., May M.L., et al. Influenza A associated morbidity and mortality in a paediatric intensive care unit. Commun Dis Intell 28 4 (2004) 504-509
16. Richard N., Hackme C., Stamm D., et al. [Influenza in pediatric intensive cure unit]. Arch Pediatr 11 7 (2004) 879-884 [in French]
17. Hon K.L., Hung E., Tang J., et al. Premorbid factors and outcome associated with respiratory virus infections in a pediatric intensive care unit. Pediatr Pulmonol 43 3 (2008) 275-280
18. Zambon M.C. Epidemiology and pathogenesis of influenza. J Antimicrob Chemother 44 Suppl B (1999) 3-9
19. Taubenberger J.K., and Morens D.M. The pathology of influenza virus infections. Annu Rev Pathol 3 (2008) 499-522
20. Hay A.J., Gregory V., Douglas A.R., et al. The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci 356 1416 (2001) 1861-1870
21. Nobusawa E., and Sato K. Comparison of the mutation rates of human influenza A and B viruses. J Virol 80 7 (2006) 3675-3678
22. Grist N.R. Epidemiology and pathogenesis of influenza. BMJ 3 5718 (1970) 344-345
23. Matsuzaki Y., Katsushima N., Nagai Y., et al. Clinical features of influenza C virus infection in children. J Infect Dis 193 9 (2006) 1229-1235
24. Katagiri S., Ohizumi A., and Homma M. An outbreak of type C influenza in a children's home. J Infect Dis 148 1 (1983) 51-56
25. Matsuzaki Y., Sugawara K., Mizuta K., et al. Antigenic and genetic characterization of influenza C viruses which caused two outbreaks in Yamagata City, Japan, in 1996 and 1998. J Clin Microbiol 40 2 (2002) 422-429
26. Peltola V., Reunanen T., Ziegler T., et al. Accuracy of clinical diagnosis of influenza in outpatient children. Clin Infect Dis 41 8 (2005) 1198-1200
27. Carrat F., Luong J., Lao H., et al. A 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemics. BMC Med 4 (2006) 26
28. Grassly N.C., and Fraser C. Mathematical models of infectious disease transmission. Microbiology. Natl Rev 6 6 (2008) 477-487
29. Mitamura K., and Sugaya N. [Diagnosis and treatment of influenza-clinical investigation on viral shedding in children with influenza]. Uirusu 56 1 (2006) 109-116 [in Japanese]
30. Hall C.B. The spread of influenza and other respiratory viruses: complexities and conjectures. [see comment]. Clin Infect Dis 45 3 (2007) 353-359
31. Weber T.P., and Stilianakis N.I. Inactivation of influenza A viruses in the environment and modes of transmission: a critical review. J Infect 57 5 (2008) 361-373
32. Cole E.C., and Cook C.E. Characterization of infectious aerosols in health care facilities: an aid to effective engineering controls and preventive strategies. Am J Infect Control 26 4 (1998) 453-464
33. Thomas Y., Vogel G., Wunderli W., et al. Survival of influenza virus on banknotes. Appl Environ Microbiol 74 10 (2008) 3002-3007
34. Bean B., Moore B.M., Sterner B., et al. Survival of influenza viruses on environmental surfaces. J Infect Dis 146 1 (1982) 47-51
35. Beigel J., and Bray M. Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res 78 1 (2008) 91-102
36. Aledort J.E., Lurie N., Wasserman J., et al. Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base. BMC Public Health 7 (2007) 208
37. Grayson M.L., Melvani S., Druce J., et al. Efficacy of soap and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hands of human volunteers. Clin Infect Dis 48 3 (2009) 285-291
38. Hota B. Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection?. Clin Infect Dis 39 8 (2004) 1182-1189
39. McDonnell G., and Russell A.D. Antiseptics and disinfectants: activity, action, and resistance. [Erratum appears in Clin Microbiol Rev 2001 Jan;14(1):227]. Clin Microbiol Rev 12 1 (1999) 147-179
40. Gorman O.T., Bean W.J., Kawaoka Y., et al. Evolution of the nucleoprotein gene of influenza A virus. J Virol 64 4 (1990) 1487-1497
41. Bano S., Naeem K., and Malik S.A. Evaluation of pathogenic potential of avian influenza virus serotype H9N2 in chickens. Avian Dis 47 3 Suppl (2003) 817-822
42. Nguyen T., Davis C.T., Stembridge W., et al. Characterization of a highly pathogenic avian influenza H5N1 virus sublineage in poultry seized at ports of entry into Vietnam. Virology 387 2 (2009) 250-256
43. Salomon R., and Webster R.G. The influenza virus enigma. Cell 136 3 (2009) 402-410
44. Webster R.G., Bean W.J., Gorman O.T., et al. Evolution and ecology of influenza A viruses. Microbiol Rev 56 1 (1992) 152-179
45. Zimmer S.M., and Burke D.S. Historical perspective-emergence of influenza A (H1N1) viruses. N Engl J Med 361 3 (2009) 279-285
46. Vainionpaa R., and Hyypia T. Biology of parainfluenza viruses. Clin Microbiol Rev 7 2 (1994) 265-275
47. Hall C.B. Respiratory syncytial virus and parainfluenza virus. [see comment]. N Engl J Med 344 25 (2001) 1917-1928
48. Lee M.S., Walker R.E., and Mendelman P.M. Medical burden of respiratory syncytial virus and parainfluenza virus type 3 infection among US children. Implications for design of vaccine trials. Hum Vaccin 1 1 (2005) 6-11
49. Lessler J., Reich N.G., Brookmeyer R., et al. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis 9 5 (2009) 291-300
50. Osiowy C. Direct detection of respiratory syncytial virus, parainfluenza virus, and adenovirus in clinical respiratory specimens by a multiplex reverse transcription-PCR assay. J Clin Microbiol 36 11 (1998) 3149-3154
51. Sato M., and Wright P.F. Current status of vaccines for parainfluenza virus infections. Pediatr Infect Dis J 27 10 Suppl (2008) S123-S125
52. Busse W.W., Gern J.E., and Dick E.C. The role of respiratory viruses in asthma. Ciba Found Symp 206 (1997) 208-213
53. Friedlander S.L., and Busse W.W. The role of rhinovirus in asthma exacerbations. J Allergy Clin Immunol 116 2 (2005) 267-273
54. Lemanske Jr. R.F., Jackson D.J., Gangnon R.E., et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. [see comment]. J Allergy Clin Immunol 116 3 (2005) 571-577
55. Kling S., Donninger H., Williams Z., et al. Persistence of rhinovirus RNA after asthma exacerbation in children. Clin Exp Allergy 35 5 (2005) 672-678
56. Pevear D.C., Tull T.M., Seipel M.E., et al. Activity of pleconaril against enteroviruses. Antimicrobial Agents Chemother 43 9 (1999) 2109-2115
57. Fleischer R., and Laessig K. Safety and efficacy evaluation of pleconaril for treatment of the common cold. [comment]. Clin Infect Dis 37 12 (2003) 1722
58. de Haan C.A., and Rottier P.J. Molecular interactions in the assembly of coronaviruses. Adv Virus Res 64 (2005) 165-230
59. Ksiazek T.G., Erdman D., Goldsmith C.S., et al. A novel coronavirus associated with severe acute respiratory syndrome. [see comment]. N Engl J Med 348 20 (2003) 1953-1966
60. Rota P.A., Oberste M.S., Monroe S.S., et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. [see comment]. Science 300 5624 (2003) 1394-1399
61. Li F., Li W., Farzan M., et al. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. [see comment]. Science 309 5742 (2005) 1864-1868
62. van der H.L., Pyrc K., Jebbink M.F., et al. Identification of a new human coronavirus. Nat Med 10 4 (2004) 368-373
63. Garcia-Garcia M.L., Calvo C., Martin F., et al. Human metapneumovirus infections in hospitalised infants in Spain. Arch Dis Child 91 4 (2006) 290-295
64. van den Hoogen B.G., de Jong J.C., Groen J., et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7 6 (2001) 719-724
65. Falsey A.R. Human metapneumovirus infection in adults. Pediatr Infect Dis J 27 10 (2008) S80-S83
66. Boivin G., De Serres G., Cote S., et al. Human metapneumovirus infections in hospitalized children. Emerg Infect Dis 9 6 (2003) 634-640
67. Nissen M.D., Siebert D.J., Mackay I.M., et al. Evidence of human metapneumovirus in Australian children. Med J Aust 176 4 (2002) 188
68. Lin P.Y., Lin T.Y., Huang Y.C., et al. Human metapneumovirus and community-acquired pneumonia in children. Chang Gung Med J 28 10 (2005) 683-688
69. Semple M.G., Cowell A., Dove W., et al. Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J Infect Dis 191 3 (2005) 382-386
70. Deffrasnes C., Hamelin M.E., and Boivin G. Human metapneumovirus. Semin Respir Crit Care Med 28 2 (2007) 213-221
71. Pelletier G., Dery P., Abed Y., et al. Respiratory tract reinfections by the new human metapneumovirus in an immunocompromised child. Emerg Infect Dis 8 9 (2002) 976-978
72. Bao X., Liu T., Shan Y., et al. Human metapneumovirus glycoprotein G inhibits innate immune responses. PLoS Pathog 4 5 (2008) e1000077
73. Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 5 11 (2005) 718-725
74. Suzuki E., Ichihara K., and Johnson A.M. Natural course of fever during influenza virus infection in children. Clin Pediatr 46 1 (2007) 76-79
75. Call S.A., Vollenweider M.A., Hornung C.A., et al. Does this patient have influenza?. [see comment]. JAMA 293 8 (2005) 987-997
76. Louie J.K., Roy-Burman A., Guardia-Labar L., et al. Rhinovirus associated with severe lower respiratory tract infections in children. Pediatr Infect Dis J 28 4 (2009) 337-339
77. Leung A.K., and Kellner J.D. Acute sinusitis in children: diagnosis and management. J Pediatr Health Care 18 2 (2004) 72-76
78. Suarez D.L., Spackman E., Senne D.A., et al. The effect of various disinfectants on detection of avian influenza virus by real time RT-PCR. Avian Dis 47 3 Suppl (2003) 1091-1095
79. Villegas P. Viral diseases of the respiratory system. Poult Sci 77 8 (1998) 1143-1145
80. Horwood F., and Macfarlane J. Pneumococcal and influenza vaccination: current situation and future prospects. Thorax 57 Suppl 2 (2002) II24-II30
81. Hilleman M.R. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 20 25-26 (2002) 3068-3087
82. Whitley R.J., and Monto A.S. Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents. J Infect Dis 194 Suppl 2 (2006) S133-S138
83. Vellozzi C., Burwen D.R., Dobardzic A., et al. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. Vaccine 27 15 (2009) 2114-2120
84. Glasgow J.F., and Middleton B. Reye syndrome-insights on causation and prognosis. Arch Dis Child 85 5 (2001) 351-353
85. Colman P.M. A novel approach to antiviral therapy for influenza. J Antimicrob Chemother 44 Suppl B (1999) 17-22
86. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 353 13 (2005) 1363-1373
87. Stephenson I., and Nicholson K.G. Chemotherapeutic control of influenza. J Antimicrob Chemother 44 1 (1999) 6-10
88. Jefferson T.O., Demicheli V., Di Pietrantonj C., et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst Rev 3 (2006) CD001265
89. Schmidt A.C. Antiviral therapy for influenza: a clinical and economic comparative review. Drugs 64 18 (2004) 2031-2046
90. Webster R.G., and Govorkova E.A. H5N1 influenza-continuing evolution and spread. [see comment]. N Engl J Med 355 21 (2006) 2174-2177
91. Sugaya N., and Takeuchi Y. Mass vaccination of schoolchildren against influenza and its impact on the influenza-associated mortality rate among children in Japan. Clin Infect Dis 41 7 (2005) 939-947
92. Cherry J.D. Clinical practice. Croup. N Engl J Med 358 4 (2008) 384-391
93. Leung A.K., Kellner J.D., and Johnson D.W. Viral croup: a current perspective. J Pediatr Health Care 18 6 (2004) 297-301
94. Bjornson C.L., Klassen T.P., Williamson J., et al. A randomized trial of a single dose of oral dexamethasone for mild croup. [see comment]. N Engl J Med 351 13 (2004) 1306-1313
95. Ledwith C.A., Shea L.M., and Mauro R.D. Safety and efficacy of nebulized racemic epinephrine in conjunction with oral dexamethasone and mist in the outpatient treatment of croup. Ann Emerg Med 25 3 (1995) 331-337
96. Jartti T., van den H.B., Garofalo R.P., et al. Metapneumovirus and acute wheezing in children. Lancet 360 9343 (2002) 1393-1394
97. Smuts H., Workman L., and Zar H.J. Role of human metapneumovirus, human coronavirus NL63 and human bocavirus in infants and young children with acute wheezing. J Med Virol 80 5 (2008) 906-912
98. Leung A.K., Kellner J.D., and Davies H.D. Respiratory syncytial virus bronchiolitis. J Natl Med Assoc 97 12 (2005) 1708-1713
99. Openshaw P.J., Dean G.S., and Culley F.J. Links between respiratory syncytial virus bronchiolitis and childhood asthma: clinical and research approaches. Pediatr Infect Dis J 22 2 Suppl (2003) S58-S64
100. Kneyber M.C.J., Steyerberg E.W., de Groot R., et al. Long-term effects of respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a quantitative review. Acta Paediatr 89 6 (2000) 654-660
101. Kellner J.D., Ohlsson A., Gadomski A.M., et al. Efficacy of bronchodilator therapy in bronchiolitis. A meta-analysis. Arch Pediatr Adolesc Med 150 11 (1996) 1166-1172
102. Kellner J.D., Ohlsson A., Gadomski A.M., et al. Bronchodilators for bronchiolitis. [see comment] [update in Cochrane Database Syst Rev. 2006;3:CD001266; PMID: 16855963]. Cochrane Database Syst Rev 2 (2000) CD001266
103. Hartling L., Wiebe N., Russell K., et al. Epinephrine for bronchiolitis. Cochrane Database Syst Rev 1 (2004) CD003123
104. Plint A.C., Johnson D.W., Patel H., et al. Epinephrine and dexamethasone in children with bronchiolitis. [see comment]. N Engl J Med 360 20 (2009) 2079-2089
105. Randolph A.G., and Wang E.E. Ribavirin for respiratory syncytial virus lower respiratory tract infection. A systematic overview. Arch Pediatr Adolesc Med 150 9 (1996) 942-947
106. Ventre K., and Randolph A. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. [update in Cochrane Database Syst Rev. 2007;(1):CD000181; PMID: 17253446] [update of Cochrane Database Syst Rev. 2000;(2):CD000181; PMID: 10796503]. Cochrane Database Syst Rev 4 (2004) CD000181
107. Ventre K., and Randolph A.G. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. [update of Cochrane Database Syst Rev. 2004;(4):CD000181; PMID: 15494991]. Cochrane Database Syst Rev 1 (2007) CD000181
108. Chen C.H., Lin Y.T., Yang Y.H., et al. Ribavirin for respiratory syncytial virus bronchiolitis reduced the risk of asthma and allergen sensitization. Pediatr Allergy Immunol 19 2 (2008) 166-172
109. Faber T.E., Kimpen J.L., and Bont L.J. Respiratory syncytial virus bronchiolitis: prevention and treatment. Expert Opin Pharmacother 9 14 (2008) 2451-2458
110. Titus M.O., and Wright S.W. Prevalence of serious bacterial infections in febrile infants with respiratory syncytial virus infection. Pediatrics 112 2 (2003) 282-284
111. Randolph A.G., Reder L., and Englund J.A. Risk of bacterial infection in previously healthy respiratory syncytial virus-infected young children admitted to the intensive care unit. Pediatr Infect Dis J 23 11 (2004) 990-994
112. Thorburn K., Harigopal S., Reddy V., et al. High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. [see comment]. Thorax 61 7 (2006) 611-615
113. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics 112 6 Pt 1 (2003) 1442-1446
114. Holman R.C., Shay D.K., Curns A.T., et al. Risk factors for bronchiolitis-associated deaths among infants in the United States. Pediatr Infect Dis J 22 6 (2003) 483-490
115. Leader S., and Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 143 5 Suppl (2003) S127-S132
116. Lind I., Gill J.H., Calabretta N., et al. Clinical inquiries. What are hospital admission criteria for infants with bronchiolitis?. J Fam Pract 55 1 (2006) 67-69
117. Wood D.W., Downes J.J., and Lecks H.I. A clinical scoring system for the diagnosis of respiratory failure. Preliminary report on childhood status asthmaticus. Am J Dis Child 123 3 (1972) 227-228
118. Brooks A.M., McBride J.T., McConnochie K.M., et al. Predicting deterioration in previously healthy infants hospitalized with respiratory syncytial virus infection. Pediatrics 104 3 Pt 1 (1999) 463-467
119. Black C.P. Systematic review of the biology and medical management of respiratory syncytial virus infection. Respir Care 48 3 (2003) 209-231
120. Perrotta C., Ortiz Z., and Roque M. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. [update in Cochrane Database Syst Rev. 2007;(1):CD004873; PMID: 17253527]. Cochrane Database Syst Rev 2 (2005) CD004873
121. Perrotta C., Ortiz Z., and Roque M. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. [update of Cochrane Database Syst Rev. 2005;(2):CD004873; PMID: 15846736]. Cochrane Database Syst Rev 1 (2007) CD004873
122. Gimenez S.F., Sanchez M.A., Battles Garrido J.M., et al. [Clinicoepidemiological characteristics of community-acquired pneumonia in children aged less than 6 years old]. Ann Pediatr 66 6 (2007) 578-584 [in Spanish]
123. Wijnands G.J. Diagnosis and interventions in lower respiratory tract infections. Am J Med 92 4A (1992) 91S-97S
124. Sandora T.J., and Harper M.B. Pneumonia in hospitalized children. Pediatr Clin North Am 52 4 (2005) 1059-1081
125. Delport S.D., and Brisley T. Aetiology and outcome of severe community-acquired pneumonia in children admitted to a paediatric intensive care unit. Suid-Afrikaanse Tydskrif Vir Geneeskunde. S Afr Med J 92 11 (2002) 907-911
126. McIntosh K. Community-acquired pneumonia in children. [see comment]. N Engl J Med 346 6 (2002) 429-437
127. Chetty K., and Thomson A.H. Management of community-acquired pneumonia in children. Paediatr Drugs 9 6 (2007) 401-411
128. Malek E., and Lebecque P. [Etiology and treatment of community acquired pneumonia in children]. J Pharm Belg 62 1 (2007) 21-24 [in French]
129. Patwari A.K., Bisht S., Srinivasan A., et al. Aetiology of pneumonia in hospitalized children. J Trop Pediatr 42 1 (1996) 15-20
130. Cilla G., Onate E., Perez-Yarza E.G., et al. Viruses in community-acquired pneumonia in children aged less than 3 years old: high rate of viral coinfection. J Med Virol 80 10 (2008) 1843-1849
131. Lucero M.G., Tupasi T.E., Gomez M.L., et al. Respiratory rate greater than 50 per minute as a clinical indicator of pneumonia in Filipino children with cough. Rev Infect Dis 12 Suppl 8 (1990) S1081-S1083
132. Albaum M.N., Hill L.C., Murphy M., et al. Interobserver reliability of the chest radiograph in community-acquired pneumonia. PORT Investigators. Chest 110 2 (1996) 343-350
133. Michelow I.C., Olsen K., Lozano J., et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. [see comment]. Pediatrics 113 4 (2004) 701-707
134. Harris J.A., Kolokathis A., Campbell M., et al. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. Pediatr Infect Dis J 17 10 (1998) 865-871
135. Kabra S.K., Lodha R., and Pandey R.M. Antibiotics for community acquired pneumonia in children. Cochrane Database Syst Rev 3 (2006) CD004874
136. Dowell S.F., Kupronis B.A., Zell E.R., et al. Mortality from pneumonia in children in the United States, 1939 through 1996. N Engl J Med 342 19 (2000) 1399-1407
137. Woo P.C., Chiu S.S., Seto W.H., et al. Cost-effectiveness of rapid diagnosis of viral respiratory tract infections in pediatric patients. J Clin Microbiol 35 6 (1997) 1579-1581
138. van Woensel J.B., von Rosenstiel I.A., Kimpen J.L., et al. Antibiotic use in pediatric intensive care patients with lower respiratory tract infection due to respiratory syncytial virus. Intensive Care Med 27 8 (2001) 1436
139. Bloomfield P., Dalton D., Karleka A., et al. Bacteraemia and antibiotic use in respiratory syncytial virus infections. Arch Dis Child 89 4 (2004) 363-367
140. Lin K.H., Lin Y.C., Chen H.L., et al. A two decade survey of respiratory adenovirus in Taiwan: the reemergence of adenovirus types 7 and 4. J Med Virol 73 2 (2004) 274-279
141. Dominguez O., Rojo P., de Las H.S., et al. Clinical presentation and characteristics of pharyngeal adenovirus infections. Pediatr Infect Dis J 24 8 (2005) 733-734
142. Castro-Rodriguez J.A., Daszenies C., Garcia M., et al. Adenovirus pneumonia in infants and factors for developing bronchiolitis obliterans: a 5-year follow-up. Pediatr Pulmonol 41 10 (2006) 947-953
143. Kim Y.-P., Hong J.-Y., Lee H.-J., et al. Genome type analysis of adenovirus types 3 and 7 isolated during successive outbreaks of lower respiratory tract infections in children. J Clin Microbiol 41 10 (2003) 4594-4599
144. Stevens T.P., Sinkin R.A., Hall C.B., et al. Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis. [see comment]. Arch Pediatr Adolesc Med 154 1 (2000) 55-61
145. McCormick J., and Tubman R. Readmission with respiratory syncytial virus (RSV) infection among graduates from a neonatal intensive care unit. Pediatr Pulmonol 34 4 (2002) 262-266
146. Liese J.G., Grill E., Fischer B., et al. Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany. Eur J Pediatr 162 4 (2003) 230-236
147. Pedersen O., Herskind A.M., Kamper J., et al. Rehospitalization for respiratory syncytial virus infection in infants with extremely low gestational age or birthweight in Denmark. Acta Paediatr 92 2 (2003) 240-242
148. Vogel A.M., Lennon D.R., Broadbent R., et al. Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infants. [see comment]. J Paediatr Child Health 38 6 (2002) 550-554
149. Feltes T.F., Cabalka A.K., Meissner H.C., et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. [see comment]. J Pediatr 143 4 (2003) 532-540
150. Hon K.L., Li A.M., Cheng F.W., et al. Personal view of SARS: confusing definition, confusing diagnoses. Lancet 361 9373 (2003) 1984-1985
151. Li A.M. Severe acute respiratory syndrome: 'SARS' or 'not SARS'. J Paediatr Child Health 40 1-2 (2004) 63-65
152. Hon KL. Just like SARS. Pediatri Pulmonol, in press.